Clinical trials
Bursitis trials in Pakistan with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 15 |
| 2023 | 12 |
| 2024 | 14 |
| 2025 | 16 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Recruiting | 17 |
| Unknown status | 15 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Riphah International University | 48 |
| Foundation University Islamabad | 8 |
| Superior University | 8 |
| Helping Hand Institute of Rehabilitation Sciences | 4 |
| University of Lahore | 4 |
| Dow University of Health Sciences | 2 |
| CMH Lahore Medical College and Institute of Dentistry | 1 |
| Elite College of Management Sciences, Gujranwala, Pakistan | 1 |
| Green International University | 1 |
| Health Education Research Foundation (HERF) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bursitis | 81 |
| Pain | 17 |
| Shoulder Pain | 9 |
| Shoulder Impingement Syndrome | 4 |
| Rotator Cuff Injuries | 3 |
| Shoulder Dislocation | 3 |
| Sprains and Strains | 3 |
| Chronic Pain | 2 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.